MDB Capital Holdings

MDBH

Market cap $29.5M

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.

Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be

MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service

New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence

Keiretsu Forum MST and MDB Capital united 150+ investors to improve syndication and exits, and will expand the Investor Summit series nationwide in 2026.

MDB Capital Holdings, LLC ( MDBH ) Q3 2025 Earnings Call November 20, 2025 4:30 PM EST Company Participants Tony Dammicci Christopher Marlett - Co-Founder, CEO & Chairman George Brandon - President, Head of Community Development & Director Presentation Tony Dammicci Welcome everyone to the MDB Capital Holdings' Third Quarter 2025 Update Conference Call. Thanks so much for joining us today.

Addison, TX, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended September 30, 2025, and subsequent developments. Third Quarter 2025 and Subsequent Operational Highlights Anticipate closing two offerings shortly: This week: $16.8 million private placement offering for Paulex Bio, a biopharmaceutical company dedicated to sourcing, developing, and commercializing novel therapeutics for the treatment of diabetes.

Addison, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Thursday November 20, 2025 at 4:30 p.m. Eastern Time to provide a business update for the third quarter 2025. A press release detailing the results will be issued prior to the call.

Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market

Presentation on Tuesday, October 21st at 10:30 AM PT Addison, Texas--(Newsfile Corp. - October 6, 2025) - MDB Capital Holdings, LLC (NASDAQ: MDBH), a public venture platform focused on launching category-leading “Big Idea” companies, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 10:30 AM PT at the Hotel del Coronado in San Diego, California. Chris Marlett, CEO & Co-Founder will be giving the presentation.